Get started
Author

Carlotta Defferrari

Efficacy of nivolumab in pre-treated non-small-cell lung cancer patients harbouring KRAS mutations
2018 · Francesco Passiglia, Federico Cappuzzo, et al. · British Journal of Cancer · 81
Sequential, Alternating, and Maintenance/Consolidation Chemotherapy in Advanced Non-Small Cell Lung Cancer: A Review of the Literature
2007 · Francesco Grossi, Marianna Aita, et al. · The Oncologist · 68
Impact of Third-Generation Drugs on the Activity of First-Line Chemotherapy in Advanced Non-Small Cell Lung Cancer: A Meta-Analytical Approach
2009 · Francesco Grossi, Marianna Aita, et al. · The Oncologist · 64
PDF
Predictors of Poor Seroconversion and Adverse Events to SARS-CoV-2 mRNA BNT162b2 Vaccine in Cancer Patients on Active Treatment
2021 · Tania Buttiron Webber, Nicoletta Provinciali, et al. · European Journal of Cancer · 43
PDF
Targeting the VEGF pathway: Antiangiogenic strategies in the treatment of non-small cell lung cancer
2008 · Marianna Aita, Gianpiero Fasola, et al. · Critical Reviews in Oncology/Hematology · 33
Prognostic Significance of VEGF after Twenty-Year Follow-up in a Randomized Trial of Fenretinide in Non–Muscle-Invasive Bladder Cancer
2016 · Matteo Puntoni, Marilena Petrera, et al. · Cancer Prevention Research · 28
PDF
Prognostic value of chromosomal imbalances, gene mutations, and BAP1 expression in uveal melanoma
2018 · Serena Patrone, Irena Maric, et al. · Genes Chromosomes and Cancer · 26
Efficacy and safety data in elderly patients with metastatic renal cell carcinoma included in the nivolumab Expanded Access Program (EAP) in Italy
2018 · Maria Giuseppa Vitale, Sarah Scagliarini, et al. · PLoS ONE · 24
An observational study of nasal cavity toxicity in cancer patients treated with bevacizumab
2014 · Mauro D’Amico, Mauro Pagano, et al. · Expert Opinion on Drug Safety · 16
Association of Biomarkers with Serious Cardiac Adverse Events during Abiraterone Acetate Treatment in Castration Resistant Prostate Cancer
2016 · Sara Campora, Eleonora Campazzi, et al. · Translational Oncology · 13
PDF
Maintenance chemotherapy in non-small cell lung cancer
2006 · M. Rinaldi, O. Belvedere, et al. · Annals of Oncology · 13
The administration of gefitinib in patients with advanced non-small-cell lung cancer after the failure of erlotinib
2012 · Francesco Grossi, Erika Rijavec, et al. · Cancer Chemotherapy and Pharmacology · 10
Patient‐ versus physician‐reported outcomes in a low‐dose tamoxifen trial in noninvasive breast cancer
2021 · Tania Buttiron Webber, Domenico Marra, et al. · The Breast Journal · 8
PDF
A randomised phase II study of docetaxel/oxaliplatin and docetaxel in patients with previously treated non-small cell lung cancer: An Alpe–Adria Thoracic Oncology Multidisciplinary group trial (ATOM 019)
2011 · Ornella Belvedere, Alessandro Follador, et al. · European Journal of Cancer · 8
Home Se-Cure: A Home Care Service for Cancer Patients during the COVID-19 Pandemic
2021 · Tania Buttiron Webber, Silvia Giuliano, et al. · International Journal of Environmental Research and Public Health · 6
PDF
A case series of low dose bevacizumab and chemotherapy in heavily pretreated patients with epithelial ovarian cancer
2012 · Carlotta Defferrari, Sara Campora, et al. · Journal of Ovarian Research · 4
PDF
B2-07: Impact of 3rd generation drugs on the activity of first-line chemotherapy in advanced non-small cell lung cancer (NSCLC): a meta-analytical approach
2007 · Francesco Grossi, Carlotta Defferrari, et al. · Journal of Thoracic Oncology · 3
Gefitinib (G) treatment outcome after progression on erlotinib (E) in patients with advanced non-small cell lung cancer (NSCLC)
2007 · F. Grossi, A. Brianti, et al. · Journal of Clinical Oncology · 3
Disease stabilization (SD) as a surrogate end-point in advanced non-small cell lung cancer (NSCLC) patients treated with erlotinib (E) or gefitinib (G)
2007 · P. Pronzato, M. Loprevite, et al. · Journal of Clinical Oncology · 3
Undifferentiated Melanoma Mimicking Pleomorphic Dermal Sarcoma: Two Additional Cases With Follow-Up Data and Short Literature Review
2025 · Alessandro Benini, Diana Carolina Ortiz, et al. · American Journal of Dermatopathology · 2
Rate of growth of Merkel cell carcinoma: a unique photographic evidence
2025 · Eleonora Bearzi, Simona Sola, et al. · Dermatology Reports · 2
PDF
The elderly patient individualized chemotherapy (EPIC) trial, a study for an aged population of non-small cell lung cancer
2019 · F. Passiglia, E. Capelletto, et al. · Annals of Oncology · 2
Efficacy and toxicity of low-doses versus standard-dose enzalutamide in advanced prostate cancer: a real-world study with implications for cancer prevention/interception
2025 · Martino Oliva, Monica Boitano, et al. · BMC Cancer · 1
Chemotherapy plus bevacizumab in the first-line treatment of non-small cell lung cancer: benefits, risks and limitations
2008 · F. Grossi, A. Brianti, et al. · memo - Magazine of European Medical Oncology · 1
6625 POSTER Gefitinib (G) treatment outcome after progression on erlotinib (E) in patients with advanced non-small-cell lung cancer (NSCLC)
2007 · F. Grossi, A. Brianti, et al. · European Journal of Cancer Supplements · 1
Works count: 48
Citation count: 467
H-index: 11
I10-index: 12
Year
Topic
Type